Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -36.11x is 12% above its 5-year average of -41.23x, near the high end of its 5-year range (-162.72x–-16.80x).
37.17% above its 12-month average of -57.47x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2027 (2026-06-30): -26.25x.
INTEREST COVERAGE RATIO
-36.11x
INTEREST COVERAGE RATIO AVG TTM
-57.47x
INTEREST COVERAGE RATIO AVG 3Y
-33.35x
INTEREST COVERAGE RATIO AVG 5Y
-41.23x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+37.17%
CURRENT VS 3Y AVG
-8.28%
CURRENT VS 5Y AVG
+12.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-523.66%
vs the sector median at left
Replimune Group, Inc.
Market Cap
$1.10B
Interest Coverage Ratio
-36.11x
TTM Avg
-57.47x
3Y Avg
-33.35x
5Y Avg
-41.23x
Market Cap
$1.09B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11B
Interest Coverage Ratio
N/A
TTM Avg
877.34x
3Y Avg
877.34x
5Y Avg
877.34x
Market Cap
$1.12B
Interest Coverage Ratio
-2.02x
TTM Avg
1.81x
3Y Avg
1.81x
5Y Avg
1.81x
Market Cap
$1.13B
Interest Coverage Ratio
1.60x
TTM Avg
1.00x
3Y Avg
0.57x
5Y Avg
0.46x
Market Cap
$1.13B
Interest Coverage Ratio
5.51x
TTM Avg
6.14x
3Y Avg
19.44x
5Y Avg
31.00x
Market Cap
$1.13B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.05B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.10B | -36.11x | -57.47x | -33.35x | -41.23x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| IRadimed Corporation (IRMD)vs › | $1.08B | N/A | N/A | N/A | N/A |
| STAAR Surgical Company (STAA)vs › | $1.11B | N/A | 877.34x | 877.34x | 877.34x |
| OPKO Health, Inc. (OPK)vs › | $1.12B | -2.02x | 1.81x | 1.81x | 1.81x |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 1.60x | 1.00x | 0.57x | 0.46x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 5.51x | 6.14x | 19.44x | 31.00x |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -13.34x | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 0.79x | 0.59x | 2.04x | 2.37x |
Interest Coverage
-36.1x
Debt/Equity
1.06
Current Ratio
5.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -26.25x |
| 2026-03-31 | -16.80x |
| 2025-12-31 | -36.30x |
| 2025-09-30 | -162.72x |
| 2025-06-30 | -45.30x |
| 2025-03-31 | -40.24x |
| 2024-12-31 | -33.38x |
| 2024-09-30 | -29.92x |
| 2024-06-30 | -29.27x |
| 2024-03-31 | -30.12x |
| 2023-12-31 | -36.43x |
| 2023-09-30 | -42.64x |
| 2023-06-30 | -33.54x |
| 2023-03-31 | -33.78x |
| 2022-12-31 | -27.96x |
| 2022-09-30 | -75.60x |
| 2022-06-30 | -74.05x |
| 2022-03-31 | -57.84x |
| 2021-12-31 | -53.51x |
| 2021-09-30 | -52.51x |
| 2021-06-30 | -49.07x |
| 2021-03-31 | -39.61x |
| 2020-12-31 | -25.12x |
| 2020-09-30 | -23.19x |
| 2020-06-30 | -21.10x |
| 2020-03-31 | -18.41x |
| 2019-12-31 | -19.98x |
| 2019-09-30 | -62.78x |
